Skip to main content
Home

oAv Menu

  • Home
  • Patient Care Center
  • Clinical Trials
  • Providers
    • Therapeutics
    • People
    • Places
  • Community Center
    • Community Stories
    • Social Media
    • Community Content
    • Financial Assistance
  • News
    • Community Events
    • Clinical Trials and Research
    • Business
    • News People
    • Happenings
    • Spotlight
    • Fundraising Events
  • Trusted Resources
    • Education
    • Videos & Visuals
  • Event Calendar
  • Login
  • Search

Patient Education

  1. Home
  2. Trusted Resources
  3. Education
  4. Patient Education
Oct 19, 2015
Why is Fluid Balance so Important for Amyloidosis Patients?
Read more
Mar 03, 2014
Understanding the Costs Related to Cancer Care
Read more
AA Amyloidosis Treatment
Treatment of AA Amyloidosis
Read more
AA Amyloidosis FAQs
Read more
AA Amyloidosis
Read more
AL Amyloidosis Matters: Coping With Emotions
Read more
A Guide to Communication and Stress
Read more
Non-Liver Transplant Therapies for ATTR Amyloidosis 2022
Read more
Therapy for AL Amyloidosis 2022
Read more
Stay Safe and Healthy in Winter
Read more

Pagination

  • « First First page
  • ‹‹ Previous page
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • ›› Next page
  • Last » Last page
Subscribe to

Newsletter

Stay informed - subscribe to our newsletter.
The subscriber's email address.

Featured Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Footer menu

  • Home
  • About us
  • Video
  • Galleries
  • Contact
  • Login
  • Privacy Policy
  • Privacy Reminder
  • Terms of use
  • FAQ
  • Code of Conduct

© 2025 Somebody To Talk To, Inc.

Join us on